Monopoly Rights for Essential Homatropine Drops

High Profit Margins in the Ophthalmic Diagnostics Segment

Homishell Edge: Reliable Mydriatic for Specialists

Secure Exclusive Territory for High-Demand Ophthalmic Niche

Low Investment, Full Technical Marketing Support
Start Your Essential Diagnostics Business Today

Homishell Eye Drop

Composition : Homatropine (2% w/v) Eye Drop

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹0/-

Please Contact For Best Price

Homishell Eye Drop (Homatropine 2% w/v) is a high-profit, essential clinical product built for our PCD Pharma Franchise partners.

This eye drop is mandatory for routine and specialized eye examinations, serving as a powerful mydriatic (pupil dilation) and cycloplegic (temporary paralysis of the focusing muscle). Its frequent use in ophthalmic clinics, hospitals, and diagnostic labs ensures stable, consistent demand for diagnostics and therapeutic treatment of conditions like uveitis.

Why Homishell is Your Key to Profit:

  1. Essential Clinical Demand: Homatropine is a non-negotiable tool for fundus examination and treating certain inflammatory eye conditions. This ensures consistent, recurring institutional revenue tied directly to routine clinical activity.

  2. Excellent Niche Margin: Positioned as an essential item in the specialty ophthalmic segment, this product commands superior pricing and secures some of the highest profit margins within its clinical niche.

  3. Clinic Loyalty: The proven efficacy and reliable duration of action of this formulation build strong prescription and procurement loyalty from ophthalmologists and their clinics.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics and diagnostic centers. Partner with us for full marketing support to capture the steady, high-value demand.

Contact us today to secure this high-margin diagnostic segment!

Read More

About the Product

Homishell Eye Drop (Homatropine 2% w/v) is a high-profit, essential clinical product built for our PCD Pharma Franchise partners.

This eye drop is mandatory for routine and specialized eye examinations, serving as a powerful mydriatic (pupil dilation) and cycloplegic (temporary paralysis of the focusing muscle). Its frequent use in ophthalmic clinics, hospitals, and diagnostic labs ensures stable, consistent demand for diagnostics and therapeutic treatment of conditions like uveitis.

Why Homishell is Your Key to Profit:

  1. Essential Clinical Demand: Homatropine is a non-negotiable tool for fundus examination and treating certain inflammatory eye conditions. This ensures consistent, recurring institutional revenue tied directly to routine clinical activity.

  2. Excellent Niche Margin: Positioned as an essential item in the specialty ophthalmic segment, this product commands superior pricing and secures some of the highest profit margins within its clinical niche.

  3. Clinic Loyalty: The proven efficacy and reliable duration of action of this formulation build strong prescription and procurement loyalty from ophthalmologists and their clinics.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics and diagnostic centers. Partner with us for full marketing support to capture the steady, high-value demand.

Contact us today to secure this high-margin diagnostic segment!

Common side effects may include temporary blurred vision, light sensitivity, or stinging upon application. Rarely, systemic absorption can cause dry mouth, rapid heartbeat, or dizziness. If severe eye pain, swelling, or allergic reactions occur, discontinue use and seek medical attention immediately.

Homishell Eye Drop is indicated for pupil dilation during eye examinations and temporary relief of pain in anterior uveitis or iritis. It facilitates accurate assessment of the retina and other intraocular structures while providing symptomatic relief from ciliary spasm and discomfort.

Use Homishell Eye Drop strictly under medical supervision. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Remove contact lenses before application and wait at least 15 minutes before reinserting them. Patients should protect their eyes from bright light after administration. Not recommended for use in patients with narrow-angle glaucoma without prior medical guidance.

Store Homishell Eye Drop in a cool, dry place below 25°C, away from direct sunlight. Keep the bottle tightly closed and out of reach of children. Discard any remaining solution after the expiry date.

Get in Touch